🇺🇸 Botulinum toxin type A injection in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Toxicity To Various Agents — 2 reports (18.18%)
2. Abasia — 1 report (9.09%)
3. Abnormal Behaviour — 1 report (9.09%)
4. Accidental Death — 1 report (9.09%)
5. Aggression — 1 report (9.09%)
6. Agitation — 1 report (9.09%)
7. Areflexia — 1 report (9.09%)
8. Axonal Neuropathy — 1 report (9.09%)
9. Bipolar I Disorder — 1 report (9.09%)
10. Cardiac Failure Congestive — 1 report (9.09%)

Source database →

Frequently asked questions

Is Botulinum toxin type A injection approved in United States?

Botulinum toxin type A injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Botulinum toxin type A injection in United States?

Hugel is the originator. The local marketing authorisation holder may differ — check the official source linked above.